{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:58:17Z","timestamp":1776081497437,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["2015-WSN-115"],"award-info":[{"award-number":["2015-WSN-115"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270630"],"award-info":[{"award-number":["81270630"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M601748"],"award-info":[{"award-number":["2016M601748"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","award":["LGY2018024"],"award-info":[{"award-number":["LGY2018024"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.biopha.2019.108623","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T15:05:50Z","timestamp":1550761550000},"page":"108623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells"],"prefix":"10.1016","volume":"112","author":[{"given":"Jichun","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7351-8239","authenticated-orcid":false,"given":"Xin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongchun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.biopha.2019.108623_bib0005","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2015","journal-title":"NEJM N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2019.108623_bib0010","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.clinthera.2010.05.003","article-title":"Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib","volume":"32","author":"Stein","year":"2010","journal-title":"Clin. Ther."},{"issue":"21","key":"10.1016\/j.biopha.2019.108623_bib0015","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1182\/blood-2008-10-184960","article-title":"Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis among patients with chronic myeloid leukemia in accelerated or blast phase","volume":"113","author":"Fava","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.biopha.2019.108623_bib0020","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3892\/or.2015.4456","article-title":"The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review)","volume":"35","author":"Di","year":"2016","journal-title":"Oncol. Rep."},{"issue":"26","key":"10.1016\/j.biopha.2019.108623_bib0025","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2017-08-801019","article-title":"Immature CML cells implement a BMP autocrine loop to escape TKI treatment","volume":"130","author":"Grockowiak","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2019.108623_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-016-0518-2","article-title":"Clinical significance of microRNAs in chronic and acute human leukemia","volume":"15","author":"Chien-Hung","year":"2016","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2019.108623_bib0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjh.12364","article-title":"MicroRNAs in myeloid malignancies","volume":"162","author":"Gordon","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.biopha.2019.108623_bib0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Machov\u00e1","year":"2011","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2019.108623_bib0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12079-011-0139-x","article-title":"MicroRNAs 130a\/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML","volume":"5","author":"Suresh","year":"2011","journal-title":"J. Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.biopha.2019.108623_bib0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12943-015-0465-3","article-title":"MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45\u03b1","volume":"14","author":"Yang","year":"2015","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2019.108623_bib0055","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1158\/0008-5472.CAN-15-2120","article-title":"miR-146b-5p within BCR-ABL1\u2013positive microvesicles promotes leukemic transformation of hematopoietic cells","volume":"76","author":"Zhang","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.108623_bib0060","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/ijlh.12351","article-title":"Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"37","author":"Fallah","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"issue":"4","key":"10.1016\/j.biopha.2019.108623_bib0065","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4499","article-title":"Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biopha.2019.108623_bib0070","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1089\/ars.2013.5184","article-title":"Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis","volume":"19","author":"Skrzypek","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.biopha.2019.108623_bib0075","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1159\/000369669","article-title":"MiR-378 promotes the migration of liver cancer cells by down-regulating Fus expression","volume":"34","author":"Ma","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2019.108623_bib0080","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3892\/ijo.2014.2283","article-title":"MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression","volume":"44","author":"Yu","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"51","key":"10.1016\/j.biopha.2019.108623_bib0085","doi-asserted-by":"crossref","first-page":"20350","DOI":"10.1073\/pnas.0706901104","article-title":"MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression","volume":"104","author":"Lee","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biopha.2019.108623_bib0090","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s12032-011-0083-x","article-title":"MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis","volume":"29","author":"Chen","year":"2012","journal-title":"Med. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2019.108623_bib0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.leukres.2013.03.014","article-title":"Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia","volume":"37","author":"Qian","year":"2013","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/j.biopha.2019.108623_bib0100","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2016.3689","article-title":"miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes","volume":"49","author":"Kuang","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2019.108623_bib0105","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1007\/s13277-015-3731-5","article-title":"High expression of OCT4 is frequent and may cause undesirable treatment outcomes in patients with acute myeloid leukemia","volume":"36","author":"Yin","year":"2015","journal-title":"Tumor Biol."},{"issue":"5052","key":"10.1016\/j.biopha.2019.108623_bib0110","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.1553558","article-title":"Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system","volume":"255","author":"Reynolds","year":"1992","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biopha.2019.108623_bib0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000486663","article-title":"Low expression of FUS1 is negatively correlated with miR-378 and may predict adverse prognoses in acute myeloid leukemia","volume":"139","author":"Tang","year":"2018","journal-title":"Acta Haematol."},{"issue":"4","key":"10.1016\/j.biopha.2019.108623_bib0120","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmet.2010.09.002","article-title":"miR-378(\u2217) mediates metabolic shift in breast cancer cells via the PGC-1\u03b2\/ERR\u03b3 transcriptional pathway","volume":"12","author":"Eichner","year":"2010","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2019.108623_bib0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1074\/jbc.M112.418830","article-title":"The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor","volume":"288","author":"Deng","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2019.108623_bib0130","doi-asserted-by":"crossref","first-page":"e44579","DOI":"10.1371\/journal.pone.0044579","article-title":"Ergosterol peroxide isolated from Ganoderma lucidum abolishes MicroRNA miR-378-mediated tumor cells on chemoresistance","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.biopha.2019.108623_bib0135","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/onc.2010.602","article-title":"Myc\/miR-378\/TOB2\/cyclin D1 functional module regulates oncogenic transformation","volume":"30","author":"Feng","year":"2011","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2019.108623_bib0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cell.2007.02.010","article-title":"Genetic and epigenetic regulators of pluripotency","volume":"128","author":"Surani","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biopha.2019.108623_bib0145","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/mrd.22266","article-title":"Induced pluripotent stem cells from goat fibroblasts","volume":"80","author":"Song","year":"2013","journal-title":"Mol. Reprod. Dev."},{"issue":"7","key":"10.1016\/j.biopha.2019.108623_bib0150","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2005-02-0734","article-title":"c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations","volume":"106","author":"Luo","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2019.108623_bib0155","doi-asserted-by":"crossref","DOI":"10.1002\/hon.2279","article-title":"Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival","volume":"35","author":"Mughal","year":"2016","journal-title":"Hematol. Oncol."},{"issue":"16","key":"10.1016\/j.biopha.2019.108623_bib0160","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1093\/nar\/gkq307","article-title":"Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells","volume":"38","author":"Eberle","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.biopha.2019.108623_bib0165","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317716629","article-title":"Expression of embryonic stem cell markers in acute myeloid leukemia","volume":"39","author":"Picot","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2019.108623_bib0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.leukres.2016.01.008","article-title":"Cell differentiation and the multiple drug resistance phenotype in human erythroleukemic cells","volume":"42","author":"Carrett-Dias","year":"2016","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.108623_bib0175","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1159\/000471246","article-title":"The construction and identification of induced pluripotent stem cells derived from acute myelogenous leukemia cells","volume":"41","author":"Zhu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2019.108623_bib0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1254\/jphs.13025FP","article-title":"Multi-drug-resistant cells enriched from chronic myeloid leukemia cells by Doxorubicin possess tumor-initiating-cell properties","volume":"122","author":"Xin","year":"2013","journal-title":"J. Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2019.108623_bib0185","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7150\/ijbs.10896","article-title":"Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition","volume":"11","author":"Kim","year":"2015","journal-title":"Int. J. Biol. Sci."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218375735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218375735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:11:56Z","timestamp":1776078716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218375735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":37,"alternative-id":["S0753332218375735"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.108623","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.108623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"108623"}}